"Your skin is the largest organ of you body. Taking care of requires effort and care. At The Skin Doctor™ we help you with rejuvenation and total skin care practices that allow you and your skin to shine. Confident and beautiful skin is our main goal for our beloved patients and as Board Certified Dermatologists, we utilize the latest scientific technology to enhance the lives of our patients. Science + Art + Beauty = You."

During the past decade, Enverus Medical Research conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 17 clinical trials were completed, i.e. on average, 70.8% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 14 clinical trials were completed. i.e. 127.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Enverus Medical Research" #1 sponsor was "Amgen" with 5 trials, followed by "Eli Lilly and Company" with 5 trials sponsored, "Dermira, Inc." with 3 trials sponsored, "Pfizer" with 3 trials sponsored and "Boehringer Ingelheim" with 3 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Enverus Medical Research" #1 collaborator was "Dermira, Inc." with 2 trials as a collaborator and "Incyte Corporation" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Enverus Medical Research" are "Psoriasis" (9 trials), "Atopic Dermatitis" (6 trials), "Acne Vulgaris" (3 trials), "Plaque Psoriasis" (3 trials) and "Alopecia Areata" (2 trials). Many other conditions were trialed in "Enverus Medical Research" in a lesser frequency.

Most popular intervention types in "Enverus Medical Research" are "Drug" (24 trials), "Other" (8 trials), "Biological" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Apremilast" (2 trials), "Baricitinib" (2 trials), "Guselkumab" (2 trials) and "Lebrikizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Enverus Medical Research" are 27 trials for "All" genders.

Currently, there are NaN active trials in "Enverus Medical Research". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 17 completed trials in Enverus Medical Research, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Enverus Medical Research, 1 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".